Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial to Correlate Early Clinical Response to Pathologic Outcome With Neoadjuvant Systemic Therapy in Patients With Early Stage Breast Cancer

NCT05020860 is registered in ClinicalTrials.gov with Baylor Breast Care Center as lead sponsor.

NCT NCT05020860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05020860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial to Correlate Early Clinical Response to Pathologic Outcome With Neoadjuvant Systemic Therapy in Patients With Early Stage Breast Cancer
Lead sponsor
Baylor Breast Care Center
Phase
Phase 2
Overall status
Recruiting
Start date
April 18, 2023
Completion date
November 30, 2029
Enrollment
185 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer female, breast cancer invasive, breast cancer stage ii, breast cancer stage iii, breast neoplasm, estrogen receptor-positive breast cancer, her2-positive breast cancer, hormone receptor-positive breast cancer, triple negative breast cancer, triple negative breast neoplasms